CD4 and myeloid sarcoma: In MS, immune cells—predominantly CD8+ T cells, CD4+ T-helper cells, and CD20+ B cells—infiltrate the CNS and promote an inflammatory response, resulting in focal demyelinating lesions and diffuse neurodegeneration [3].